Skip to main content
Industry Partner Session

IPS03: The Challenge of Measuring Healthcare Quality in a Post-pandemic World

AMIA Industry Partner Session 2021

The Challenge of Measuring Healthcare Quality in a Post-pandemic World

Prior to the COVID-19 pandemic, the US healthcare system introduced new rules to improve interoperability and data sharing (21st Century Cures Act). Long-standing regulatory incentives to measure and improve quality required the flow of good data between providers/institutions, payers and regulators. “Good” was initially defined as standardized, process-level data elements which were relatively easily extracted from existing information flows. The pandemic demonstrated that those data streams were not sufficient to respond to public health emergencies, stratify patients or assess outcomes effectively. Capturing detailed clinical data at the point of care must be persisted through the information ecosystem if we hope to provide an effective database to support public health, research and measure outcome of our healthcare system. This panel will describe the state of affairs in quality measurement, the problems of poor data quality, and key concepts to capture, persist and transform complex clinical data to support the future, post-pandemic health system. 


Dale Sanders (Presenter)
Intelligent Medical Objects, Inc.

Steven Rube, MD, FAMIA (Presenter)
Intelligent Medical Objects, Inc.

Margaret E. O’Kane, MPH (Presenter)
National Committee for Quality Assurance (NCQA)

Andrew S. Kanter, MD, MPH, FACMI, FAMIA (Presenter)
Intelligent Medical Objects, Inc.